This inventor holds 1 USPTO granted patent. Top assignee: G.d. Searle & Company. Active years: 1989.
Company Filing History:
Years Active: 1989
Title: Earl G. Burton: Innovator in Pharmaceutical Chemistry
Introduction
Earl G. Burton is a notable inventor based in Deerfield, IL (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. His work focuses on creating innovative solutions that enhance the efficacy and safety of medications.
Latest Patents
Earl G. Burton holds a patent for "Diol metabolites of 7-phenyl-1,2,4-triazolo[2,3-c]pyrimidines-5-amines." This invention describes a novel glycol of a triazolopyrimidine diuretic, specifically 1-(5-Amino-7-phenyl-[1,2,4] triazolo [1,5,c]pyrimidin-8-yl)-1,2-ethan diol. The compound exhibits fewer cardiotoxic side effects than the parent compound while maintaining diuretic activity. The invention also includes compositions incorporating the metabolite and methods of its use, along with pharmaceutically acceptable salts thereof.
Career Highlights
Earl G. Burton has had a distinguished career at G.D. Searle & Company, where he has contributed to various research and development projects. His innovative approach to drug design has led to advancements in the pharmaceutical industry, particularly in the area of diuretics.
Collaborations
Throughout his career, Earl has collaborated with esteemed colleagues, including Christopher P. Chengelis and Gerald M. Walsh. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in pharmaceutical research.
Conclusion
Earl G. Burton's contributions to pharmaceutical chemistry exemplify the impact of innovation in medicine. His patented work on diuretic compounds highlights the importance of developing safer and more effective therapeutic options. His career continues to inspire future generations of inventors in the field.